Active, Not Recruiting
A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)
NCT05394116
- Conditions
- Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +5 more
- Locations
-
- University of California Los Angeles (UCLA) Medical Center Los Angeles, California, United States
- Vanderbilt University Medical Center Nashville, Tennessee, United States
- Royal North Shore Hospital St Leonards, New South Wales, Australia
- Hospital Israelita Albert Einstein São Paulo, Brazil